{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:44:25Z","timestamp":1790221465279,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Since the introduction of allogeneic bone marrow transplantation (BMT) as a treatment for aplastic anemia (AA), major advances have occurred, such as refinements in conditioning regimens, graft-versus-host disease (GVHD) prophylaxis, high-resolution HLA typing, pretransplant transfusion practices, and general supportive care. We present a comprehensive retrospective single-center cohort study of 607 children and adults who underwent allogeneic transplantation for AA over 6 decades at a single BMT center. We highlight key temporal changes in conditioning strategies for related donor transplantation, GVHD prophylaxis, and HLA matching that correspond with improved nonrelapse mortality, reduced GVHD rates, and better overall survival among HLA-matched related and unrelated donor transplants. This work provides a historical perspective on the evolution of BMT for AA among HLA-matched related and unrelated donor recipients and identifies persistent barriers to curative therapy, including patient age and donor availability. Further studies are needed to clarify the role of antithymocyte globulin in conditioning regimens, improve GVHD prevention and management, and expand the use of alternative donors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018548","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:23:29Z","timestamp":1770236609000},"page":"2661-2675","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-4941","authenticated-orcid":false,"given":"Daniel","family":"Olivieri","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of Washington, Seattle WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8176-6371","authenticated-orcid":false,"given":"Megan","family":"Othus","sequence":"additional","affiliation":[{"name":"2Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong","family":"Vo","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"4Division of Hematology and Oncology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-3341","authenticated-orcid":false,"given":"Roland B.","family":"Walter","sequence":"additional","affiliation":[{"name":"4Division of Hematology and Oncology, University of Washington, Seattle, WA"},{"name":"5Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprasad","family":"Manjappa","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"4Division of Hematology and Oncology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Basom","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-4099","authenticated-orcid":false,"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"4Division of Hematology and Oncology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siob\u00e1n","family":"Keel","sequence":"additional","affiliation":[{"name":"3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"4Division of Hematology and Oncology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"11","key":"2026042809472089600_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM198203183061105","article-title":"Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med"},{"key":"2026042809472089600_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.1964.03060380009002","article-title":"Recovery from marrow failure following isogenic marrow infusion","volume":"188","author":"Thomas","year":"1964","journal-title":"JAMA"},{"issue":"16","key":"2026042809472089600_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","article-title":"Bone-marrow transplantation (first of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"issue":"7745","key":"2026042809472089600_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(72)90292-9","article-title":"Aplastic anaemia treated by marrow transplantation","volume":"1","author":"Thomas","year":"1972","journal-title":"Lancet"},{"issue":"3","key":"2026042809472089600_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"12","key":"2026042809472089600_bib6","first-page":"1155","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the American Society for Transplantation and Cellular Therapy","volume":"30","author":"Iftikhar","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"2026042809472089600_bib7","first-page":"105.e1","article-title":"Upfront alternative donor transplant versus immunosuppressive therapy in patients with severe aplastic anemia who lack a fully HLA-matched related donor: systematic review and meta-analysis of retrospective studies, on behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Alotaibi","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2026042809472089600_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"issue":"4","key":"2026042809472089600_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","article-title":"Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"2026042809472089600_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"issue":"25","key":"2026042809472089600_bib11","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"22","key":"2026042809472089600_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"2026042809472089600_bib13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2026042809472089600_bib14","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2026042809472089600_bib15","first-page":"43","article-title":"Marrow transplant experience for children with severe aplastic anemia","volume":"16","author":"Sanders","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"6","key":"2026042809472089600_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood.V48.6.817.817","article-title":"Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle","volume":"48","author":"Storb","year":"1976","journal-title":"Blood"},{"issue":"10","key":"2026042809472089600_bib17","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood.V89.10.3890","article-title":"Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"issue":"1","key":"2026042809472089600_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41409-021-01498-1","article-title":"Cancers after HLA-matched related bone marrow transplantation for aplastic anemia","volume":"57","author":"Vo","year":"2022","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"2026042809472089600_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V45.3.355.355","article-title":"Selection of patients for bone marrow transplantation in severe aplastic anemia","volume":"45","author":"Camitta","year":"1975","journal-title":"Blood"},{"key":"2026042809472089600_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41375-024-02172-3","article-title":"Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"38","author":"Olivieri","year":"2024","journal-title":"Leukemia"},{"issue":"5","key":"2026042809472089600_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11764-020-00968-7","article-title":"Neighborhood deprivation index is associated with weight status among long-term survivors of childhood acute lymphoblastic leukemia","volume":"15","author":"Oluyomi","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"3","key":"2026042809472089600_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"issue":"10","key":"2026042809472089600_bib23","doi-asserted-by":"crossref","first-page":"E2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026042809472089600_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2026042809472089600_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"3","key":"2026042809472089600_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.leu.2404119","article-title":"Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes","volume":"20","author":"Matsui","year":"2006","journal-title":"Leukemia"},{"issue":"15","key":"2026042809472089600_bib27","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","article-title":"Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment","volume":"2","author":"Georges","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"2026042809472089600_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00007890-198207000-00006","article-title":"Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance","volume":"34","author":"Deeg","year":"1982","journal-title":"Transplantation"},{"issue":"12","key":"2026042809472089600_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"issue":"10","key":"2026042809472089600_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jama.1976.03270110029022","article-title":"Bone marrow transplantation from donors with aplastic anemia. A report from the ACS\/NIH bone marrow transplant registry","volume":"236","year":"1976","journal-title":"JAMA"},{"issue":"2","key":"2026042809472089600_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197701132960201","article-title":"Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection","volume":"296","author":"Storb","year":"1977","journal-title":"N Engl J Med"},{"issue":"2","key":"2026042809472089600_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V59.2.236.236","article-title":"Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients","volume":"59","author":"Storb","year":"1982","journal-title":"Blood"},{"issue":"4","key":"2026042809472089600_bib33","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4049\/jimmunol.112.4.1508","article-title":"Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum","volume":"112","author":"Storb","year":"1974","journal-title":"J Immunol"},{"issue":"2","key":"2026042809472089600_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.107.2.409","article-title":"The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings","volume":"107","author":"Storb","year":"1971","journal-title":"J Immunol"},{"issue":"10","key":"2026042809472089600_bib35","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1182\/blood.V79.10.2566.2566","article-title":"Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone","volume":"79","author":"Doney","year":"1992","journal-title":"Blood"},{"issue":"1","key":"2026042809472089600_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0887-7963(00)80114-5","article-title":"Leukocyte reduction of blood components: public policy and new technology","volume":"14","author":"Dzik","year":"2000","journal-title":"Transfus Med Rev"},{"issue":"6","key":"2026042809472089600_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-199112000-00004","article-title":"Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood","volume":"52","author":"Bean","year":"1991","journal-title":"Transplantation"},{"issue":"8","key":"2026042809472089600_bib38","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1080\/10428194.2016.1266624","article-title":"Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"58","author":"Arai","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2026042809472089600_bib39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","article-title":"Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia","volume":"101","author":"Frickhofen","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2026042809472089600_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bmt.2009.7","article-title":"The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies","volume":"43","author":"Gratwohl","year":"2009","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026042809472089600_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41409-018-0153-1","article-title":"Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report","volume":"53","author":"Passweg","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2026042809472089600_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/asheducation-2018.1.467","article-title":"Alternative donor transplants for severe aplastic anemia","volume":"2018","author":"Bacigalupo","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"2026042809472089600_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/ehm.11.11","article-title":"Clinical management of aplastic anemia","volume":"4","author":"Dezern","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"2026042809472089600_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.10899","article-title":"Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient","volume":"92","author":"Maury","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"2026042809472089600_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1705894","article-title":"Recent improvement in outcome of unrelated donor transplantation for aplastic anemia","volume":"41","author":"Viollier","year":"2008","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026042809472089600_bib46","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2009.006916","article-title":"Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen","volume":"94","author":"Maury","year":"2009","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2661\/2514061\/blooda_adv-2025-018548-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2661\/2514061\/blooda_adv-2025-018548-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:47:37Z","timestamp":1777384057000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2661\/566427\/Allogeneic-hematopoietic-cell-transplantation-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018548","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,16]]}}}